These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1041 related articles for article (PubMed ID: 19079604)
1. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. Throsby M; van den Brink E; Jongeneelen M; Poon LL; Alard P; Cornelissen L; Bakker A; Cox F; van Deventer E; Guan Y; Cinatl J; ter Meulen J; Lasters I; Carsetti R; Peiris M; de Kruif J; Goudsmit J PLoS One; 2008; 3(12):e3942. PubMed ID: 19079604 [TBL] [Abstract][Full Text] [Related]
2. Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge. Nachbagauer R; Shore D; Yang H; Johnson SK; Gabbard JD; Tompkins SM; Wrammert J; Wilson PC; Stevens J; Ahmed R; Krammer F; Ellebedy AH J Virol; 2018 Aug; 92(16):. PubMed ID: 29899095 [TBL] [Abstract][Full Text] [Related]
3. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes. Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119 [TBL] [Abstract][Full Text] [Related]
4. Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody. Wyrzucki A; Dreyfus C; Kohler I; Steck M; Wilson IA; Hangartner L J Virol; 2014 Jun; 88(12):7083-92. PubMed ID: 24719426 [TBL] [Abstract][Full Text] [Related]
5. A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses. De Marco D; Clementi N; Mancini N; Solforosi L; Moreno GJ; Sun X; Tumpey TM; Gubareva LV; Mishin V; Clementi M; Burioni R PLoS One; 2012; 7(4):e34415. PubMed ID: 22496802 [TBL] [Abstract][Full Text] [Related]
6. A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection. Sakabe S; Iwatsuki-Horimoto K; Horimoto T; Nidom CA; Le Mt; Takano R; Kubota-Koketsu R; Okuno Y; Ozawa M; Kawaoka Y Antiviral Res; 2010 Dec; 88(3):249-55. PubMed ID: 20849879 [TBL] [Abstract][Full Text] [Related]
7. Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient. Hu W; Chen A; Miao Y; Xia S; Ling Z; Xu K; Wang T; Xu Y; Cui J; Wu H; Hu G; Tian L; Wang L; Shu Y; Ma X; Xu B; Zhang J; Lin X; Bian C; Sun B Virology; 2013 Jan; 435(2):320-8. PubMed ID: 23084424 [TBL] [Abstract][Full Text] [Related]
9. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Li GM; Chiu C; Wrammert J; McCausland M; Andrews SF; Zheng NY; Lee JH; Huang M; Qu X; Edupuganti S; Mulligan M; Das SR; Yewdell JW; Mehta AK; Wilson PC; Ahmed R Proc Natl Acad Sci U S A; 2012 Jun; 109(23):9047-52. PubMed ID: 22615367 [TBL] [Abstract][Full Text] [Related]
10. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design. Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889 [TBL] [Abstract][Full Text] [Related]
11. A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses. Hu H; Voss J; Zhang G; Buchy P; Zuo T; Wang L; Wang F; Zhou F; Wang G; Tsai C; Calder L; Gamblin SJ; Zhang L; Deubel V; Zhou B; Skehel JJ; Zhou P J Virol; 2012 Mar; 86(6):2978-89. PubMed ID: 22238297 [TBL] [Abstract][Full Text] [Related]
12. H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model. CarreƱo JM; Strohmeier S; Kirkpatrick Roubidoux E; Hai R; Palese P; Krammer F mBio; 2020 Dec; 11(6):. PubMed ID: 33323511 [TBL] [Abstract][Full Text] [Related]
13. Antibody recognition of a highly conserved influenza virus epitope. Ekiert DC; Bhabha G; Elsliger MA; Friesen RH; Jongeneelen M; Throsby M; Goudsmit J; Wilson IA Science; 2009 Apr; 324(5924):246-51. PubMed ID: 19251591 [TBL] [Abstract][Full Text] [Related]
14. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497 [TBL] [Abstract][Full Text] [Related]
15. Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Kashyap AK; Steel J; Oner AF; Dillon MA; Swale RE; Wall KM; Perry KJ; Faynboym A; Ilhan M; Horowitz M; Horowitz L; Palese P; Bhatt RR; Lerner RA Proc Natl Acad Sci U S A; 2008 Apr; 105(16):5986-91. PubMed ID: 18413603 [TBL] [Abstract][Full Text] [Related]
16. A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head. Benjamin E; Wang W; McAuliffe JM; Palmer-Hill FJ; Kallewaard NL; Chen Z; Suzich JA; Blair WS; Jin H; Zhu Q J Virol; 2014 Jun; 88(12):6743-50. PubMed ID: 24696468 [TBL] [Abstract][Full Text] [Related]
17. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus. Wu CY; Yeh YC; Chan JT; Yang YC; Yang JR; Liu MT; Wu HS; Hsiao PW PLoS One; 2012; 7(8):e42363. PubMed ID: 22879951 [TBL] [Abstract][Full Text] [Related]
18. Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses. Wan H; Gao J; Xu K; Chen H; Couzens LK; Rivers KH; Easterbrook JD; Yang K; Zhong L; Rajabi M; Ye J; Sultana I; Wan XF; Liu X; Perez DR; Taubenberger JK; Eichelberger MC J Virol; 2013 Aug; 87(16):9290-300. PubMed ID: 23785204 [TBL] [Abstract][Full Text] [Related]
19. A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses. Boonsathorn N; Panthong S; Koksunan S; Chittaganpitch M; Phuygun S; Waicharoen S; Prachasupap A; Sasaki T; Kubota-Koketsu R; Yasugi M; Ono K; Arai Y; Kurosu T; Sawanpanyalert P; Ikuta K; Watanabe Y Biochem Biophys Res Commun; 2014 Sep; 452(3):865-70. PubMed ID: 25204499 [TBL] [Abstract][Full Text] [Related]
20. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. Corti D; Suguitan AL; Pinna D; Silacci C; Fernandez-Rodriguez BM; Vanzetta F; Santos C; Luke CJ; Torres-Velez FJ; Temperton NJ; Weiss RA; Sallusto F; Subbarao K; Lanzavecchia A J Clin Invest; 2010 May; 120(5):1663-73. PubMed ID: 20389023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]